Checklist For Identifying Cancer Patients In Secondary Data

Published May 17, 2013
Bolton, MA, USA - The use of secondary data sources is growing in oncology health services research. Identifying patients with cancer from these data can be difficult due to the lack of clinical detail in secondary data. As a result, researchers develop algorithms or groups of codes to identify specific groups of cancer patients in secondary data. Therefore, researchers must critically evaluate whether published algorithms are suitable for their studies or develop and defend their own algorithm. The ISPOR Oncology Good Outcomes Research Practices Working Group reviewed articles using secondary data to study cancer populations. Findings from the review were used to develop a checklist for identifying potential methodological and reporting issues using secondary data. This checklist will assist decision makers and reviewers to evaluate the quality of studies using secondary data and provide guidance for researchers working with secondary data. Kathy L. Schulman, MA, Principal at Outcomes Research Solutions and first author of the study comments, “Secondary data are critical in oncology health services research. We hope this checklist will facilitate the standardization of reporting and reviewing of future publications.” The full study, “A Checklist for Ascertaining Study Cohorts in Oncology Health Services Research Using Secondary Data: Report of the ISPOR Oncology Good Outcomes Research Practices Working Group,” is published in Value in Health.

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

New Research Collection Reveals How Artificial Intelligence Is Reshaping Health Economics

Nov 6, 2025

The PhRMA Foundation and ISPOR announced the publication of a special themed section of research papers that explores the dynamic intersection of artificial intelligence (AI) and health economics and outcomes research (HEOR).

ISPOR Announces 2025 Health Economics and Outcomes Research Award Honorees

Oct 20, 2025

ISPOR announced the recipients of its 2025 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards. ISPOR Scientific Awards are designed to foster and recognize excellence and outstanding achievement in HEOR and its Leadership Awards recognize excellence and outstanding leadership in the field.

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×